Found 79 results
Author Title Type [ Year(Asc)]
Filters: Author is Clemons, Traci E  [Clear All Filters]
2015
Chew, E. Y., Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., et al.. (2015). Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial. Am J Ophthalmol, 159(4), 659-666.e1. presented at the 2015 Apr. doi:10.1016/j.ajo.2014.12.013
Sallo, F. B., Leung, I., Clemons, T. E., Peto, T., Bird, A. C., & Pauleikhoff, D.. (2015). Multimodal imaging in type 2 idiopathic macular telangiectasia. Retina, 35(4), 742-9. presented at the 2015 Apr. doi:10.1097/IAE.0000000000000365
2014
Chamberlain, J. M., Okada, P., Holsti, M., Mahajan, P., Brown, K. M., Vance, C., et al.. (2014). Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA, 311(16), 1652-60. presented at the 2014 Apr 23-30. doi:10.1001/jama.2014.2625
2013
Niskopoulou, M., Balaskas, K., Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., & Peto, T.. (2013). Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?. Br J Ophthalmol, 97(7), 946-8. presented at the 2013 Jul. doi:10.1136/bjophthalmol-2013-303118
Clemons, T. E., Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Wang, J. Jin, et al.. (2013). Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3. Ophthalmic Epidemiol, 20(2), 109-13. presented at the 2013 Apr. doi:10.3109/09286586.2013.766757